Dutch radiation therapy firm Nucletron has gained U.S. Food and Drug Administration 510(k) clearance for its Spot Pro 3-D ultrasound planning system for all seed-implant techniques. The product covers all planning aspects, including pre-planning, intra-operative live-planning, and post-treatment dosimetry, according to the Veenendaal, Netherlands-based firm.
The unit is available as a stand-alone treatment-planning system for all manual seed implant techniques, and can also be integrated into the vendor’s FIRST (fully integrated real-time seed treatment) system, an automated technique for seed-implant procedures, the company said.
By AuntMinnie.com staff writersNovember 20, 2002
Related Reading
Nucletron, Novation enter three-year accord, October 17, 2002
FDA clears brachytherapy breast irradiation device, October 9, 2002
Nucletron to become Zmed sales agent, July 5, 2002
Nucletron names Coats as president, June 13, 2002
Nucletron installs first ThoraScan digital chest system, March 14, 2002
Copyright © 2002 AuntMinnie.com
